Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Stryker dishes out $135 million for Concentric Medical
Stryker Corp. expands its footprint in the neurovascular space with a $135 million all-cash deal for Concentric Medical Inc. and its stroke treatment devices. Stryker Corp. (NYSE:SYK) agreed acquire Concentric Medical Inc. in a deal expected to close by the end of the year.
2. The BRIC bubble might be in for a flatline
Med-tech companies may not get as much bang for their buck in emerging markets, according to Goldman Sachs. The predicted flat 7.9 growth for the BRIC nations of Brazil, Russia, India and China through 2012 could be bad news for the clutch of med-tech titans who have just committed big bucks on the growth of emerging markets.
1. Breast implant recall is a no-go
FDA officials decided that a lack of consistent postmarket data gathering wasn’t enough to spur a recall.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!